Challenges of vaccination and herd immunity in COVID-19 and management strategiesArticle Published on 2022-11-012022-11-16 Journal: The clinical respiratory journal [Category] SARS, 변종, [키워드] acute respiratory syndrome caused challenge contagious coronavirus Coronavirus disease 2019 country COVID-19 COVID-19 vaccination COVID-19 vaccine Critical death Defense effective eligible help herd immunity Hospitalization Immunity management mutant Outbreaks prevention PROTECT reduce reducing risk SARS-CoV-2 SARS-CoV-2 variant severe disease Spread susceptible the disease vaccination variants viral disease virus [DOI] 10.1111/crj.13543 PMC 바로가기
COVID-19 impact on the emergency and hospitalization of a tertiary hospital. Management lessons learnedArticle Published on 2022-11-012023-07-09 Journal: Enfermedades infecciosas y microbiologia clinica ( [Category] COVID19(2023년), [키워드] Clinical management COVID-10 COVID-19 Gestión clínica Hospitalización Hospitalization Pandemia pandemic Pediatric emergencies Urgencias pediátricas. [DOI] 10.1016/j.eimce.2022.06.001 PMC 바로가기
Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infectionResearch article Published on 2022-11-012022-10-05 Journal: Multiple sclerosis and related disorders [Category] 진단, [키워드] adjusted Admission admitted to ICU association Clinical outcome COVID-19 cross-sectional diagnosis of COVID-19 Disease-modifying therapies Electronic health record General population health systems Healthcare provider Hospital admission Hospitalization Hospitalized ICU immunomodulatory immunosuppressive in-hospital mortality increased risk Infection Iran Mortality mortality risk multiple sclerosis outcome Patient patients with COVID-19 PCR Result risk risk factor Severe COVID-19 Infection severity therapy vaccinated against COVID-19 were recorded [DOI] 10.1016/j.msard.2022.104067 [Article Type] Research article
Exploratory analysis of interleukin-38 in hospitalized COVID-19 patientsArticle Published on 2022-11-012022-11-15 Journal: Immunity, Inflammation and Disease [Category] SARS, 바이오마커, [키워드] Adaptive immune response Admission age Analysis anti-inflammatory effect anti-inflammatory properties binding Biomarker cartilage CD244 CHL1 circulating Clinical data Cohort cohorts Concentration concentrations coronavirus disease correlated correlation COVID-19 COVID-19 patient COVID-19 severity disease dismutase dysregulated enzyme-linked immunosorbent exploratory fatty healthy control healthy controls healthy subjects hospital Hospitalization hospitalized COVID-19 patient hospitalized COVID-19 patients IL-1 Immunoglobulin in viral increase in infections Inflammatory biomarker intensive care interleukin-38 investigated men moderate Mortality no difference outcome plasma positive correlation positively correlated progression Protein proximity extension assay recent receptor reduce retrieved retrospective cohort study SARS-CoV-2 SERPINA12 severity shown subjects thrombocyte TNF TNFRSF9 validation cohort were measured while women [DOI] 10.1002/iid3.712 PMC 바로가기
Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-A Danish nationwide cohort studyArticle Published on 2022-11-012022-11-16 Journal: American journal of transplantation : official jou [Category] COVID19(2023년), SARS, 변종, [키워드] 95%CI acute respiratory syndrome Analysis assisted respiration calculate clinical research/practice Cohort cohort study comparable Contact coronavirus Cox regression death Effect General population hospital Hospitalization incidence rate increased risk increased the risk individual Infection infection and infectious agents - viral infection and infectious agents - viral: SARS-CoV-2/COVID-19 infectious agent Infectious disease lower risk Mortality omicron organ performed recipient reduce reduced risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV2 infection severe COVID-19 solid organ transplant solid organ transplantation vaccination Vaccinations variant were used with COVID-19 [DOI] 10.1111/ajt.17142 PMC 바로가기
Comparative epidemiology of five waves of COVID-19 in Mexico, March 2020-August 2022Article Published on 2022-10-312022-11-16 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI age analyzed Antigen association average calculated Care case fatality rates Comorbidities Comparative confirmed case confirmed cases COVID-19 COVID-19 case Critical death declined decrease Demographic factors Epidemic epidemic wave epidemiological Epidemiology estimates Factors Fatality rate FIVE Gender Health highest hospital Hospital admission Hospitalization hospitalizations Hospitalized In-hospital In-hospital death in-hospital mortality incidence increase in individual Intubated intubation intubations laboratory-confirmed male Metrics notable omicron pandemic Patient patients with comorbidities recorded reduction in Regression model risk SARS-CoV-2 second wave security severe disease severity subsequent Surveillance symptoms onset System vaccination variant were recorded [DOI] 10.1186/s12879-022-07800-w PMC 바로가기
SARS-CoV-2-Naïve Korean Children and Adolescents Hospitalized With COVID-19 in 2021Article Published on 2022-10-312022-11-16 Journal: Journal of Korean medical science [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome adjusted odds ratio Adolescent Affect children clinical manifestation conditions coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 severity Critical evaluated had no hospital Hospitalization Hospitalized Illness severity Isolation Korean less Medical conditions medical need Mild moderate multicenter obesity outcome Patient Pneumonia proportion respiratory Retrospective study risk risk factor SARS-CoV-2 SARS-CoV-2 variants severe acute respiratory syndrome coronavirus 2 severe COVID-19 severity South Korea vaccination against COVID-19 variant with COVID-19 [DOI] 10.3346/jkms.2022.37.e303 PMC 바로가기
Bamlanivimab Use in a Military Treatment FacilityArticle Published on 2022-10-292022-11-15 Journal: Military Medicine [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome Administered administration Admission analyzed approval approved Arm bamlanivimab Care caused cohort study coronavirus coronavirus disease COVID-19 COVID-19 patient death declined diagnosed Disease progression facility FDA Follow-up Guidance help hospital Hospital admission Hospitalization information initial inpatient admission institutional review board intravenous IRB lack Mild-to-moderate monoclonal antibody Patient patients patients with SARS-CoV-2 placebo group Prevent Primary outcome progression provided receiving replicated reported required retrospective risk risk factor SARS-CoV-2 secondary outcome self-reported symptom severe COVID-19 small sample size Spread statistical significance statistically significant Study design Symptom treated Treatment treatment group virus-neutralizing was obtained were given Wuhan, China [DOI] 10.1093/milmed/usab188 PMC 바로가기
Notes From the Field: Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability – United States, December 23, 2021-August 28, 2022Article Published on 2022-10-282022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] 치료제, [키워드] Analysis Antiviral collected COVID-19 COVID-19 therapeutics Critical death Department Dispensing distribution drug Emergency use authorization EUA FDA food higher risk highlight Hospitalization Human indicated Intervention medication medium Mild Moderate COVID-19 molnupiravir oral Patient Paxlovid provide recipient reduce risk service United States vulnerability [DOI] 10.15585/mmwr.mm7143a3 PMC 바로가기
Influenza Incidence and Vaccine Effectiveness During the Southern Hemisphere Influenza Season – Chile, 2022Article Published on 2022-10-282022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 치료기술, [키워드] absence affected Atypical benefit clade close contact Community country COVID-19 pandemic COVID-19 vaccine cumulative Effectiveness eligible Epidemics Face mask Hemisphere Hospitalization incidence include Influenza influenza infection Influenza virus measure Measures pandemic partner physical distancing Pneumonia Precaution reduce SARS-CoV-2 season severe disease southern hemisphere the United State Transmission vaccination Vaccine virus [DOI] 10.15585/mmwr.mm7143a1 PMC 바로가기